广生堂：GST-HG131暂未开展单药三期临床

Group 1 - The company has not yet initiated the Phase III clinical trial for GST-HG131 as a monotherapy [2] - The Phase II clinical trial for GST-HG131 in combination with GST-HG141 for the treatment of chronic hepatitis B has been approved [2] - The company will fulfill its information disclosure obligations in accordance with relevant regulatory requirements regarding future clinical progress [2]